Medeon Biodesign, Inc.
TWO: 6499.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Yue-Teh Jang
- Employees
- 39
- Headquarters
- Taipei, Taiwan
- IPO year
- 2014
- Market cap
- NT$7.9B
- Website
- https://www.medeonbio.com
Loading 6499…
Loading profile data…Frequently asked questions about 6499
What does Medeon Biodesign, Inc. (6499.TWO) do?
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States. The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port s...
Where does 6499.TWO trade?
Medeon Biodesign, Inc. (6499.TWO) trades on the Taipei Exchange.
What sector is 6499.TWO in?
Medeon Biodesign, Inc. (6499.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Medeon Biodesign, Inc.?
Yue-Teh Jang is the chief executive officer of Medeon Biodesign, Inc. (6499.TWO).
Where is Medeon Biodesign, Inc. headquartered?
Medeon Biodesign, Inc. is headquartered in Taiwan.
Does 6499.TWO pay a dividend?
Medeon Biodesign, Inc. (6499.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6499.TWO go public?
Medeon Biodesign, Inc. (6499.TWO) completed its initial public offering in 2014.